Kymera CLO sells 6,371 shares for tax withholding
Kymera Therapeutics’ chief legal officer automatically sold shares to cover RSU tax withholding, not as a discretionary trade.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kymera Therapeutics, Inc. (KYMR) reported that Chief Legal Officer Brian Adams sold a total of 6,371 shares of common stock on September 4, 2026. The company states these sales were required to cover tax withholding obligations upon vesting of restricted stock units and occurred automatically, not at his discretion. No Rule 10b5-1 trading plan is reported.
Insider Trade Summary
Net Seller: 6,371 shares
Net Sell
3 txns
Insider
Adams Brian
Role
Chief Legal Officer
Sold
6,371 shs ($744K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,209 | $115.55 | $140K |
| Sale | Common Stock F1, F3 | 3,025 | $116.81 | $353K |
| Sale | Common Stock F1, F4 | 2,137 | $117.57 | $251K |
Holdings After Transaction:
Common Stock — 50,254 shares (Direct)
Footnotes (4)
- F1. Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $117.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $117.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Total shares sold: 6,371 shares
Shares sold at $115.55: 1,209 shares
Shares sold at $116.81: 3,025 shares
+2 more
5 metrics
Total shares sold
6,371 shares
Common stock sold on September 4, 2026 to cover tax withholding
Shares sold at $115.55
1,209 shares
Common stock sale on September 4, 2026 at weighted average $115.55
Shares sold at $116.81
3,025 shares
Common stock sale on September 4, 2026 at weighted average $116.81
Shares sold at $117.57
2,137 shares
Common stock sale on September 4, 2026 at weighted average $117.57
Price ranges
$115.09–$117.85 per share
Ranges of multiple trades underlying the three weighted average sale prices
Key Terms
restricted stock units, tax withholding obligations, weighted average price
3 terms
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to cover tax withholding obligations in connection with the vesting"
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KYMR report for its Chief Legal Officer?
Kymera Therapeutics reported that Chief Legal Officer Brian Adams sold 6,371 shares of common stock on September 4, 2026. The company states the shares were sold to satisfy tax withholding obligations tied to vesting restricted stock units and that the sales were automatic.
Were the KYMR insider sales made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as being made under a plan, and the footnotes explain the sales were executed automatically to cover tax withholding on vesting restricted stock units, rather than at the reporting person’s discretion.
How many separate KYMR sale transactions are disclosed in this Form 4?
The Form 4 discloses three non-derivative sale transactions in Kymera Therapeutics common stock on September 4, 2026, totaling 6,371 shares. Each transaction has its own weighted average sale price and price range described in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
